Skip to main content

SJR76 Alabama 2014 Session

Updated Jan 14, 2026
SJR76 Alabama 2014 Session
Senate Bill
Enacted
Current Status
Regular Session 2014
Session
15
Sponsors

Summary

Session
Regular Session 2014
Title
Muscular Dystrophy, Duchenne, Food and Drug Administration urged to grant accelerated approval for the drug eteplirsen for treatment
Description
Muscular Dystrophy, Duchenne, Food and Drug Administration urged to grant accelerated approval for the drug eteplirsen for treatment.
Subjects
Resolutions, Legislative

Bill Actions

H

Assigned Act No. 2014-171.

H

Signature Requested

S

Enrolled

S

Passed Second House

H

McCutcheon motion to Concur In and Adopt adopted Voice Vote

H

Reported from Rules

H

Received in House of Representatives and referred to the House of Representatives committee on Rules

S

Brewbaker motion to Adopt adopted Voice Vote

S

Introduced

Bill Text

Documents

Source: Alabama Legislature